Submitted by: Submitted by HexaReport
Views: 10
Words: 959
Pages: 4
Category: Business and Industry
Date Submitted: 10/03/2016 03:50 AM
Hexa Reports
Market Research Reports and Insightful Company Profiles
Transcatheter Valve Market Analysis, Share and Size,
Emerging Trends, Growth, Overview And Segment
Forecasts To 2024
The global transcatheter valve market is anticipated to reach a value of USD 8.62 billion by 2024,
according to a new report by Grand View Research, Inc. The market is currently under-penetrated as
these products are approved only for geriatric patients who cannot undergo normal valve surgeries.
Growth drivers such as increasing prevalence of chronic cardiovascular diseases, increasing economic
development, improvement in reimbursement scenario, and faster adoption of new technologies are
expected to significantly improve the usage rates over the forecast period.
Browse Detail Report With TOC @
http://www.hexareports.com/report/transcatheter-valve-market/details
The transcatheter valve market is evolving rapidly due to the continuous investments in R&D by the key
market players such as Edwards Life Sciences, Medtronic, St. Jude, and Boston Scientific. The
technologically advanced products such as the SAPIEN 3 transcatheter heart valve and the TRINITY Valve
are designed to reduce the surgical complications and improve patient compliance. For instance, the
TRINITY TAVI system enables easy retrieval and repositioning of the device, without compromising on
patient safety and treatment outcomes.
Furthermore, the market is expected to experience strong tailwinds on account of growing investor
interest, lucrative product pipeline, faster regulatory approvals, and high competition to acquire
Hexa Reports
Market Research Reports and Insightful Company Profiles
potential start-ups. For example, some of the notable investments in the market include the USD 37
million funding of Venus MedTech by Goldman Sachs. In line with the market trends, the other market
participants such as Boston Scientific, Edward Life Sciences, and Medtronic have also increased their
investments to develop new...